ARTICLE | Company News
MorphoSys, Institute of Cancer Research deal
November 15, 2010 8:00 AM UTC
MorphoSys' research and diagnostic antibodies unit AbD Serotec received exclusive, worldwide rights to the institute's bromodeoxyuridine (BrdU) antibody clone, BU1/75, for research applications, inclu...